Regencell Bioscience Holdings (RGC) Liabilities and Shareholders Equity (2020 - 2025)
Regencell Bioscience Holdings (RGC) reported Liabilities and Shareholders Equity of $3.0 million for Q4 2025, down 47.64% quarter-over-quarter from $5.8 million in Q2 2025.
Regencell Bioscience Holdings (RGC) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends
Regencell Bioscience Holdings has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $3.0 million in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity changed N/A year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2025 stood at $21.4 million (changed N/A YoY), and the FY2025 full-year result was $5.8 million, changed N/A from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $3.0 million, down from $5.8 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $12.6 million in Q2 2023, with the low at $3.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 4.91 Bn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 2.35 Bn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 401.53 Mn |
| 10 | Regencell Bioscience Holdings | - | - | - | 3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.01 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Jun 30, 2023 | 12.62 Mn |
| Jun 30, 2020 | 514,018.00 |